On September 27, the European health community held an event in the European Parliament to express their concern on Brexit negotiations and to point out to insufficient attention given to health sector. The speakers stressed that health sector and patients' representatives should be prioritised in the negotiations and that there are serious concerns regarding the Brexit impact on patients and public health. Please find the summary of the debate below.

Documents:

Press release (stakeholders' statements)

Agenda

brexit meeting

You are invited  attend the event: ‘Maximise the value and the impact of health research in Europe’ organised by the BioMed Alliance and chaired by Paul Rübig, MEP & 1st Vice-Chair STOA, to be held at Square de Meeûs, 29, Brussels, on Wednesday April 25 from 10h30 – 12h30.

High level speakers include Annika Nowak, member of the cabinet of Commissioner Andriukaitis, Line Matthiessen, Acting Director, Health Directorate, European Commission, DG Research and Innovation and Karin Sipido, Chair, Scientific Panel for Health, European Commission. Discussions will focus on the upcoming Framework Programme 9, and will highlight the impact and societal value of health research. Speakers from across different biomedical sectors will address policies issues such as EU funding, EU research projects and collaborations, synergies between national and EU research programmes and long term vision and strategies.

For additional information and registration please contact Loredana Simulescu, BioMed Alliance policy officer. Tel: 32 (0) 22741073, This email address is being protected from spambots. You need JavaScript enabled to view it.

You can find the programe here

Presentations

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.